"Some of us think the long-term benefits of grafts are not proven," said Dr. Lederle, an internist who is directing one of the clinical trials and takes no money from the industry. But grafts, he said, are a huge market, widely promoted. "This has created tension in the field," he added. Dr. Calonge of the task force said the question for insurers was going to be whether to pay for the screening. He knows that world well, he says, because until a few years ago he was the chief of preventive medicine for the Kaiser Permanente health care company in Colorado and had to decide whether new tests and services should be provided.
Well on that we certainly agree. I'd venture that someone is always out to make a buck.